Clinical trial
Retrospective Case Study to Determine the Correlation of Patient Outcome to the ChemoFx Assay in Cases With Late Stage Endometrial Cancer
NCT01049126 is registered in ClinicalTrials.gov with Precision Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Case Study to Determine the Correlation of Patient Outcome to the ChemoFx Assay in Cases With Late Stage Endometrial Cancer
- Lead sponsor
- Precision Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- February 28, 2010
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer